Stock Catalyst AI
?? VIP Login VIP €10

Ticker archive · $BIIB

$BIIB Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $BIIB — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$BIIB

$BIIB – Biogen Q3 Adj. EPS $2.62 vs. $2.06 Est., Beats Revenue and Narrows FY EPS Guidance Upward

· TELEGRAM · All $BIIB
?? Positive AI Sentiment (+6.8 / 10)
  • Q3 Adj. EPS of $2.62 beats consensus estimate of $2.06; Revenue reaches $2.80B vs. $2.64B expected.
  • Product revenue beat at $2.09B, driven by MS revenue of $919M.
  • FY Adj. EPS guidance floor raised to $12.20-$13.00 (previously $12.00-$13.00) vs. $12.38 consensus.
Observed market reaction after signal
4h +2.20% · Peak +2.31%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?
$BIIB

$BIIB – Biogen Reports Q3 Earnings Beat, Raises Lower End of FY Adj. EPS Guidance

· TELEGRAM · All $BIIB
?? Positive AI Sentiment (+6.5 / 10)
  • Q3 Adj. EPS of $2.62 beats consensus estimate of $2.06; Revenue reaches $2.80B vs. $2.64B est.
  • Key product Spinraza outpaces expectations at $460.6M vs. $398.8M est.
  • FY Adj. EPS guidance raised to $12.20-$13.00 (prior: $12.00-$13.00; consensus: $12.38).
Observed market reaction after signal
4h +2.20% · Peak +2.31%
Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?
$BIIB

$BIIB – Biogen Reports Q3 2026 Revenue of $2.8B (+11%), GAAP Diluted EPS of $(0.14)

BIOGEN INC.
· SEC_8K · All $BIIB
? Neutral AI Sentiment (-1.0 / 10)
  • Total Q3 revenue increased 11% YoY to $2.80B, led by growth portfolio contributions from acquired Apellis assets.
  • GAAP diluted EPS declined to $(0.14) due to transaction charges, while Non-GAAP diluted EPS reached $2.62.
  • Legacy MS franchise contracted 13% YoY to $919M, offsetting gains in rare diseases (+27%).
Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?